AxoGen, Inc. (AXGN)
NASDAQ: AXGN · IEX Real-Time Price · USD
9.12
+0.15 (1.67%)
At close: Jul 19, 2024, 4:00 PM
9.13
+0.01 (0.11%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
AxoGen Market Cap
AxoGen has a market cap or net worth of $398.59 million as of July 22, 2024. Its market cap has increased by 14.60% in one year.
Market Cap
398.59M
Enterprise Value
447.02M
1-Year Change
14.60%
Ranking
Category
Stock Price
$9.12
Market Cap Chart
Since December 1, 1998, AxoGen's market cap has increased from $12.20M to $398.59M, an increase of 3,167.10%. That is a compound annual growth rate of 14.56%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 398.60M | 35.58% |
Dec 29, 2023 | 294.00M | -30.33% |
Dec 30, 2022 | 422.00M | 8.37% |
Dec 31, 2021 | 389.40M | -45.79% |
Dec 31, 2020 | 718.30M | 1.73% |
Dec 31, 2019 | 706.10M | -10.63% |
Dec 31, 2018 | 790.10M | -16.55% |
Dec 29, 2017 | 946.80M | 219.76% |
Dec 30, 2016 | 296.10M | 98.19% |
Dec 31, 2015 | 149.40M | 113.43% |
Dec 31, 2014 | 70.00M | -10.14% |
Dec 31, 2013 | 77.90M | 159.67% |
Dec 31, 2012 | 30.00M | 1.35% |
Dec 30, 2011 | 29.60M | 97.33% |
Dec 31, 2010 | 15.00M | -12.79% |
Dec 31, 2009 | 17.20M | 45.76% |
Dec 31, 2008 | 11.80M | 118.52% |
Dec 31, 2007 | 5.40M | 100.00% |
Dec 29, 2006 | 2.70M | 28.57% |
Dec 30, 2005 | 2.10M | -65.00% |
Dec 31, 2004 | 6.00M | 87.50% |
Dec 31, 2003 | 3.20M | 60.00% |
Dec 31, 2002 | 2.00M | -60.78% |
Dec 31, 2001 | 5.10M | -30.14% |
Dec 29, 2000 | 7.30M | 15.87% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sonida Senior Living | 407.46M |
Esperion Therapeutics | 407.30M |
Cerus | 406.76M |
Alto Neuroscience | 402.99M |
Precigen | 401.35M |
Lyell Immunopharma | 397.70M |
enGene Holdings | 397.05M |
Organogenesis Holdings | 384.46M |